Abstract

SARS-CoV-2 virions are surrounded by a lipid bilayer that contains membrane proteins such as spike, responsible for target-cell binding and virus fusion. We found that during SARS-CoV-2 infection, spike becomes lipid modified, through the sequential action of the S-acyltransferases ZDHHC20 and 9. Particularly striking is the rapid acylation of spike on 10 cytosolic cysteines within the ER and Golgi. Using a combination of computational, lipidomics, and biochemical approaches, we show that this massive lipidation controls spike biogenesis and degradation, and drives the formation of localized ordered cholesterol and sphingolipid-rich lipid nanodomains in the early Golgi, where viral budding occurs. Finally, S-acylation of spike allows the formation of viruses with enhanced fusion capacity. Our study points toward S-acylating enzymes and lipid biosynthesis enzymes as novel therapeutic anti-viral targets.

Highlights

  • The CoV membrane envelope has 3 primary structural proteins: spike (S), membrane (M), and envelope (E) (Boson et al, 2021; Siu et al, 2008; V’kovski et al, 2021) as well as accessory proteins such as Orf3a (Ito et al, 2005; Tan et al, 2004)

  • Infections were performed with the severe acute respiratory syndrome (SARS)-CoV-2 D614G variant, which appeared early during the pandemic and rapidly spread worldwide (Korber et al, 2020)

  • Acylation prevents premature degradation promoting the biogenesis of spike, which is subsequently transported to the ER-Golgi intermediate compartment (ERGIC) where it arrives with up to 30 acyl chains decorating each trimer

Read more

Summary

Introduction

The CoV membrane envelope has 3 primary structural proteins: spike (S), membrane (M), and envelope (E) (Boson et al, 2021; Siu et al, 2008; V’kovski et al, 2021) as well as accessory proteins such as Orf3a (Ito et al, 2005; Tan et al, 2004). Viral assembly only requires E and M (Boson et al, 2021; Siu et al, 2008; Vennema et al, 1996). S is essential for infectivity as it mediates attachment to host cell receptors, angiotensin-converting enzyme 2 (ACE2) for SARS-CoV-2 (Hoffmann et al, 2020b; Letko et al, 2020), and fusion between viral and target cell membranes

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call